Seugnet et al., 2009 - Google Patents
Identifying sleep regulatory genes using a Drosophila model of insomniaSeugnet et al., 2009
View PDF- Document ID
- 2092302804177138671
- Author
- Seugnet L
- Suzuki Y
- Thimgan M
- Donlea J
- Gimbel S
- Gottschalk L
- Duntley S
- Shaw P
- Publication year
- Publication venue
- Journal of Neuroscience
External Links
Snippet
Although it is widely accepted that sleep must serve an essential biological function, little is known about molecules that underlie sleep regulation. Given that insomnia is a common sleep disorder that disrupts the ability to initiate and maintain restorative sleep, a better …
- 230000007958 sleep 0 title abstract description 167
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Seugnet et al. | Identifying sleep regulatory genes using a Drosophila model of insomnia | |
| Jiang et al. | Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications | |
| Brodkin et al. | Identification of quantitative trait loci that affect aggressive behavior in mice | |
| Scarpa et al. | Shared transcriptional signatures in major depressive disorder and mouse chronic stress models | |
| Sunagawa et al. | Mammalian reverse genetics without crossing reveals Nr3a as a short-sleeper gene | |
| Dockendorff et al. | Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest | |
| Lee et al. | Closing in on mechanisms of open neural tube defects | |
| Huguet et al. | The genetic landscapes of autism spectrum disorders | |
| Blazejewski et al. | Neurodevelopmental genetic diseases associated with microdeletions and microduplications of chromosome 17p13. 3 | |
| Fergestad et al. | Metabolic disruption in Drosophila bang-sensitive seizure mutants | |
| Sugino et al. | Cell-type-specific repression by methyl-CpG-binding protein 2 is biased toward long genes | |
| McDermid et al. | Genomic disorders on 22q11 | |
| Huang et al. | Molecular and neural functions of Rai1, the causal gene for Smith-Magenis syndrome | |
| Oksenberg et al. | The role of AUTS2 in neurodevelopment and human evolution | |
| Kume et al. | Dopamine is a regulator of arousal in the fruit fly | |
| Ricard et al. | Phenotypic consequences of copy number variation: insights from Smith-Magenis and Potocki-Lupski syndrome mouse models | |
| Reed et al. | Systems genomics of metabolic phenotypes in wild-type Drosophila melanogaster | |
| Dib-Hajj et al. | Translational pain research: Lessons from genetics and genomics | |
| Mathies et al. | SWI/SNF chromatin remodeling regulates alcohol response behaviors in Caenorhabditis elegans and is associated with alcohol dependence in humans | |
| Hu et al. | Mutations in PTRH2 cause novel infantile‐onset multisystem disease with intellectual disability, microcephaly, progressive ataxia, and muscle weakness | |
| Harbison et al. | Genome-wide association study of circadian behavior in Drosophila melanogaster | |
| Wu et al. | Drosophila Nipped-B mutants model Cornelia de Lange syndrome in growth and behavior | |
| Mori et al. | Audition-independent vocal crystallization associated with intrinsic developmental gene expression dynamics | |
| Johnson et al. | Genetic influences on response to novel objects and dimensions of personality in Papio baboons | |
| De Benedictis et al. | Inherited variability of the mitochondrial genome and successful aging in humans |